The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
The Systemic Inflammatory Response to Cardiopulmonary Bypass: Pathophysiological, Therapeutic, and Pharmacological Considerations
Abstract
Cardiac surgery and cardiopulmonary bypass (CPB) activate a systemic inflammatory response characterized clinically by alterations in cardiovascular and pulmonary function. Significant morbidity is rare (approximately 1%-2% of cases), but when severe acute lung injury occurs, mortality is high (50%-70%) [1]. However, most patients undergoing CPB experience some degree of organ dysfunction as a result of activation of the inflammatory response. The purpose of this review is to examine the recent developments in our understanding of the pathophysiological mechanisms responsible for this response, the treatment modalities that have been used to ameliorate it, and the possible implications of these findings for the conduct of anesthesia for cardiac surgery. Pathophysiology Initiation of the Systemic Inflammatory Response The systemic inflammatory response may be initiated during cardiac surgery by a number of processes, including blood contact with the foreign surface of the CPB apparatus [2], development of ischemia and reperfusion injury [3], and presence of endotoxemia [4]. In the course of cardiac surgery using CPB, all three processes (i.e., blood contact activation, ischemia and reperfusion injury, and endotoxemia) are present and contribute concurrently to the humoral and cellular development of the processes leading to the systemic inflammatory response (Figure 1). The extent and duration of the response is influenced by many factors, including the pharmacological agents used to ameliorate the response [3,5-36] (see Table 1, Table 3, and Table 4 and the discussion in the section on therapeutic strategies) (pharmacological), the composition of the priming solution [37-39], the presence of pulsatile perfusion [40,41], the use of mechanical filtration [42-47], the type of oxygenator [6,7,40,42,48-55], the type of extracorporeal circuit [56-64], and the temperature during CPB [6,7,37-44,46-50,52-70] (see Table 2 and Table 5 and the discussion in the section on therapeutic strategies) (mechanical) [4,66-71]. Excellent reviews of the role of complement activation [72] and the effects of ischemia-reperfusion [73,74] have been published previously. We have chosen in this review to focus on the roles of endotoxin release and initiation of cytokine activation, mechanisms that have been relatively recently elucidated.Figure 1: Pathways leading to activation of the systemic inflammatory response syndrome (SIRS) and sites of therapeutic intervention. Therapeutic interventions: 1 = mechanical factors, 2 = glucocorticoids, 3 = pentoxyphylline, 4 = protease inhibitors, 5 = gut therapy. TNF alpha = tumor necrosis factor alpha, IL = interleukin, CPB = cardiopulmonary bypass, DIC = disseminated intravascular coagulation.Table 1: Randomized Trials of Pharmacological Interventions Designed to Reduce the Systemic Inflammatory Response That Occur During Cardiac SurgeryTable 3: Table 1 (Continued)Table 4: Table 1 (Continued)Table 2: Randomized Trials of Mechanical Strategies to Reduce the Systemic Inflammatory Response During Cardiac SurgeryTable 5: Table 2 (Continued)Increased concentrations of endotoxin, a lipopolysaccharide associated with cell membranes of Gramnegative microorganisms (Figure 2), have been measured in plasma during CPB [4,9,13,15,29,30,75,76]. The source and significance of these increases are currently debated. A reduction in splanchnic blood flow has been observed during CPB [77]. It has been hypothesized that this may be associated with the subsequent translocation of endotoxin across the ischemic gut wall, with activation of the systemic inflammatory response [73]. Increased levels of endotoxin have been measured in venous blood from the splanchnic vascular bed during CPB [78], and levels of endotoxin are correlated with the degree of hemodynamic compromise and aortic cross-clamp time (i.e., duration of relative ischemia) during cardiac surgery [75]. Furthermore, sequential elevation of endotoxin followed by increased levels of inflammatory cytokines has been observed [79], and in the elderly, the degree of myocardial dysfunction after CPB correlates with the level of endotoxin measured [80]. Finally, studies of treatments designed to reduce gut endotoxin levels [29,30] or to improve gut perfusion [76] show some efficacy. On the other hand, there have been disturbing inconsistencies in the studies of the role of endotoxin in relation to cardiac surgery and CPB. Investigators have measured endotoxin levels in a variety of fluids other than blood, including the CPB priming fluid and the intravenous solutions used before initiating CPB [81]. In some studies, investigators have been unable to measure increases in endotoxin levels at any time during CPB [82] or to correlate measured levels with organ dysfunction [83]. There have also been problems with the sensitivity and specificity of the endotoxin assay used in some studies [15]. Despite these difficulties, we believe that current data suggest that the ph
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Circulating adhesion molecules in cardiac operations: Influence of high-dose aprotinin
Boldt, J., Osmer, C., Schindler, E., Linke, L. C., Stertmann, W. A., & Hempelmann, G. (1995) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(94)00851-w · Cited by 32
RetractedThe L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,987
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
Nitric oxide: an endogenous modulator of leukocyte adhesion.
Kubes, P., Suzuki, M., & Granger, D. N. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4651 · Cited by 3,029
Van Snick, J. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.001345 · Cited by 1,890
Structure and Function of Lipopolysaccharide Binding Protein
Schumann, R. R., Leong, S. R., Flaggs, G. W., Gray, P. W., Wright, S. D., Mathison, J. C., Tobias, P. S., & Ulevitch, R. J. (1990) · Science · doi:10.1126/science.2402637 · Cited by 1,672
Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric Oxide
Finkel, M. S., Oddis, C. V., Jacob, T. D., Watkins, S. C., Hattler, B. G., & Simmons, R. L. (1992) · Science · doi:10.1126/science.1631560 · Cited by 1,628
Pathogenetic Mechanisms of Septic Shock
Epstein, F. H., & Parrillo, J. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282008 · Cited by 1,548
Complement and the damaging effects of cardiopulmonary bypass
Kirklin, J. K., Westaby, S., Blackstone, E. H., Kirklin, J. W., Chenoweth, D. E., & Pacifico, A. D. (1983) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)39061-0 · Cited by 1,325
Cited by
ACC/AHA guidelines for coronary artery bypass graft surgery
Eagle, K. A., Guyton, R. A., Davidoff, R., Ewy, G. A., Fonger, J., Gardner, T. J., Gott, J. P., Herrmann, H. C., Marlow, R. A., Nugent, W. C., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00389-7 · Cited by 1,995
Thiele, H., Sick, P., Boudriot, E., Diederich, K.-W., Hambrecht, R., Niebauer, J., & Schuler, G. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi161 · Cited by 661
Cardiogenic Shock Complicating Acute Myocardial Infarction: Expanding the Paradigm
Hochman, J. S. (2003) · Circulation · doi:10.1161/01.cir.0000075927.67673.f2 · Cited by 641
Holte, K., & Kehlet, H. (2002) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(02)01491-6 · Cited by 408
Halonen, J., Halonen, P., Järvinen, O., Taskinen, P., Auvinen, T., Tarkka, M., Hippeläinen, M., Juvonen, T., Hartikainen, J., & Hakala, T. (2007) · JAMA · doi:10.1001/jama.297.14.1562 · Cited by 331
Metadata
- Authors
- Hall, R. I., Smith, M. S., & Rocker, G.
- Venue
- Anesthesia & Analgesia
- Published
- 1997-10
- Volume
- 85
- Issue
- 4
- Pages
- 766-782
- ISSN
- 0003-2999 (ISSN-L)
- OpenAlex
- W2087467622
- Cited by
- 407
- References
- 117
- FWCI
- 14.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Systemic Inflammatory Response to Cardiopulmonary Bypass: Pathophysiological, Therapeutic, and Pharmacological Considerations. https://app.cochat.ai/papers/10.1097/00000539-199710000-00011
- The paper
- Hall, R. I., Smith, M. S., & Rocker, G. (1997). The Systemic Inflammatory Response to Cardiopulmonary Bypass: Pathophysiological, Therapeutic, and Pharmacological Considerations. Anesthesia & Analgesia. https://doi.org/10.1097/00000539-199710000-00011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.